共 312 条
[21]
Scott DA(2007)A randomized controlled trial to assess the efficacy of tiotropium in Canadian patients with chronic obstructive pulmonary disease Can Respir J 14 465-55
[22]
Itzler R(2010)Efficacy of a new once-daily long-acting inhaled beta2-agonist indacaterol versus twice-daily formoterol in COPD Thorax 65 473-62
[23]
Cappelleri JC(2002)A 6-month, placebo-controlled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterol Chest 122 47-108
[24]
Baker WL(2010)Once-daily bronchodilators for chronic obstructive pulmonary disease: Indacaterol versus tiotropium Am J Respir Crit Care Med 182 155-43
[25]
Baker EL(2008)Effect of fluticasone propionate/salmeterol (250/50 microg) or salmeterol (50 microg) on COPD exacerbations Respir Med 102 1099-9
[26]
Coleman CI(2003)The efficacy and safety of fluticasone propionate (250 microg)/salmeterol (50 microg) combined in the Diskus inhaler for the treatment of COPD Chest 124 834-91
[27]
Dong YH(2007)Impact of salmeterol/fluticasone propionate versus salmeterol on exacerbations in severe chronic obstructive pulmonary disease Am J Respir Crit Care Med 175 144-65
[28]
Lin HH(2002)Effectiveness of fluticasone propionate and salmeterol combination delivered via the Diskus device in the treatment of chronic obstructive pulmonary disease Am J Respir Crit Care Med 166 1084-69
[29]
Shau WY(2009)Efficacy and tolerability of budesonide/formoterol in one hydrofluoroalkane pressurized metered-dose inhaler in patients with chronic obstructive pulmonary disease: results from a 1-year randomized controlled clinical trial Drugs 69 549-81
[30]
Wu YC(2002)Comparison of the efficacy, tolerability, and safety of formoterol dry powder and oral, slow-release theophylline in the treatment of COPD Chest 121 1058-20